F16.259

Hallucinogen dependence with hallucinogen-induced psychotic disorder, unspecified

Billable FY2026 2025-10-01 → 2026-09-30

This is the unspecified option. 2 more specific codes sit alongside it. Worth checking whether the documentation supports one of them.

Exclusions 3 never code together

Excludes1

Excludes2

symptoms, signs and abnormal clinical laboratory findings, not elsewhere classified (R00-R99)R00-R99

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Excludes2 — not included here, but the patient may have both. Code both when documented.

Instructional notes 4

F16code

Includes

Includes

Index entries leading here 2

Dependence (on) (syndrome) F19.20
- drug NEC F19.20
  - hallucinogen F16.20
    - with
      - psychosis F16.259
Disorder (of) — see also Disease
- hallucinogen use
  - moderate or severe F16.20
    - with
      - hallucinogen-induced
        
        psychotic disorder F16.259
- phencyclidine use
  - moderate or severe F16.20
    - with
      - phencyclidine-induced
        
        psychotic disorder F16.259

Alongside this code 2 same parent — F16.25

Additional references

AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

CMS22HCC54 CMS28HCC135 ESRD21HCC54 ESRD24HCC54

Presence is a property of the code. Untick a model to hide it everywhere.

Present FY2024–FY2027.